Perlegen's Series B Round

Perlegen raised a round of funding on January 14, 2003.

Perlegen Sciences, Inc. uses high-density, whole-wafer microarray technology in combination with new approaches to sample preparation to scan entire human genomes. The company's first objective was to…

Articles about Perlegen's Series B Round: